These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1468 related articles for article (PubMed ID: 32641482)
1. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2. Zhao X; Zheng S; Chen D; Zheng M; Li X; Li G; Lin H; Chang J; Zeng H; Guo JT J Virol; 2020 Aug; 94(18):. PubMed ID: 32641482 [TBL] [Abstract][Full Text] [Related]
2. LY6E impairs coronavirus fusion and confers immune control of viral disease. Pfaender S; Mar KB; Michailidis E; Kratzel A; Boys IN; V'kovski P; Fan W; Kelly JN; Hirt D; Ebert N; Stalder H; Kleine-Weber H; Hoffmann M; Hoffmann HH; Saeed M; Dijkman R; Steinmann E; Wight-Carter M; McDougal MB; Hanners NW; Pöhlmann S; Gallagher T; Todt D; Zimmer G; Rice CM; Schoggins JW; Thiel V Nat Microbiol; 2020 Nov; 5(11):1330-1339. PubMed ID: 32704094 [TBL] [Abstract][Full Text] [Related]
3. Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses. Zhao X; Sehgal M; Hou Z; Cheng J; Shu S; Wu S; Guo F; Le Marchand SJ; Lin H; Chang J; Guo JT J Virol; 2018 Mar; 92(6):. PubMed ID: 29263263 [TBL] [Abstract][Full Text] [Related]
4. Properties of Coronavirus and SARS-CoV-2. Malik YA Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926 [TBL] [Abstract][Full Text] [Related]
5. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein. Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194 [TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction. Kim CH Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730 [TBL] [Abstract][Full Text] [Related]
7. COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection. Messina F; Giombini E; Agrati C; Vairo F; Ascoli Bartoli T; Al Moghazi S; Piacentini M; Locatelli F; Kobinger G; Maeurer M; Zumla A; Capobianchi MR; Lauria FN; Ippolito G; J Transl Med; 2020 Jun; 18(1):233. PubMed ID: 32522207 [TBL] [Abstract][Full Text] [Related]
8. COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2. Mittal A; Manjunath K; Ranjan RK; Kaushik S; Kumar S; Verma V PLoS Pathog; 2020 Aug; 16(8):e1008762. PubMed ID: 32822426 [TBL] [Abstract][Full Text] [Related]
9. Repurposing old drugs as antiviral agents for coronaviruses. Yang CW; Peng TT; Hsu HY; Lee YZ; Wu SH; Lin WH; Ke YY; Hsu TA; Yeh TK; Huang WZ; Lin JH; Sytwu HK; Chen CT; Lee SJ Biomed J; 2020 Aug; 43(4):368-374. PubMed ID: 32563698 [TBL] [Abstract][Full Text] [Related]
10. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity. Zhu Y; Yu D; Yan H; Chong H; He Y J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627 [TBL] [Abstract][Full Text] [Related]
11. Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2. Verkhivker G Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158276 [TBL] [Abstract][Full Text] [Related]
12. [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).]. Lvov DK; Alkhovsky SV Vopr Virusol; 2020; 65(2):62-70. PubMed ID: 32515561 [TBL] [Abstract][Full Text] [Related]
13. Corona virus versus existence of human on the earth: A computational and biophysical approach. Zehra Z; Luthra M; Siddiqui SM; Shamsi A; Gaur NA; Islam A Int J Biol Macromol; 2020 Oct; 161():271-281. PubMed ID: 32512089 [TBL] [Abstract][Full Text] [Related]
15. HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV. Milewska A; Chi Y; Szczepanski A; Barreto-Duran E; Dabrowska A; Botwina P; Obloza M; Liu K; Liu D; Guo X; Ge Y; Li J; Cui L; Ochman M; Urlik M; Rodziewicz-Motowidlo S; Zhu F; Szczubialka K; Nowakowska M; Pyrc K J Virol; 2021 Jan; 95(4):. PubMed ID: 33219167 [TBL] [Abstract][Full Text] [Related]
16. Characterization of CCoV-HuPn-2018 spike protein-mediated viral entry. Liu Y; Chen D; Wang Y; Li X; Qiu Y; Zheng M; Song Y; Li G; Song C; Liu T; Zhang Y; Guo JT; Lin H; Zhao X J Virol; 2023 Sep; 97(9):e0060123. PubMed ID: 37676001 [TBL] [Abstract][Full Text] [Related]
17. Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2. Li X; Zai J; Zhao Q; Nie Q; Li Y; Foley BT; Chaillon A J Med Virol; 2020 Jun; 92(6):602-611. PubMed ID: 32104911 [TBL] [Abstract][Full Text] [Related]
18. The current landscape of coronavirus-host protein-protein interactions. Perrin-Cocon L; Diaz O; Jacquemin C; Barthel V; Ogire E; Ramière C; André P; Lotteau V; Vidalain PO J Transl Med; 2020 Aug; 18(1):319. PubMed ID: 32811513 [TBL] [Abstract][Full Text] [Related]
19. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses. Fung SY; Yuen KS; Ye ZW; Chan CP; Jin DY Emerg Microbes Infect; 2020; 9(1):558-570. PubMed ID: 32172672 [TBL] [Abstract][Full Text] [Related]
20. The Integral Membrane Protein ZMPSTE24 Protects Cells from SARS-CoV-2 Spike-Mediated Pseudovirus Infection and Syncytia Formation. Shilagardi K; Spear ED; Abraham R; Griffin DE; Michaelis S mBio; 2022 Oct; 13(5):e0254322. PubMed ID: 36197088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]